The growth of the global disposable insulin pens market is attributed to several factors including rising population of diabetes patients, high rate of adoption, ergonomic design, and increasing popularity of such pens among consumers. Additionally, disposable pens aid in avoiding under or over dosage of insulin and thus are highly recommended by doctors.
Moreover, increasing demand for human insulin analogue, rising governmental support as well as advancements in technology in the field of insulin pens are some other key aspects driving the global disposable insulin pens market.
An important factor driving the growth of the global insulin pen market is the increased prevalence of diabetes in different age groups. However, safety issues regarding usage of disposable insulin pens and stringent regulations for new product development are anticipated to hinder market growth during forecast period. The global diabetes disposable insulin pen market is anticipated to expand at a CAGR close to 5.0% during the forecast period.
North America held majority market share in 2018 owing to the presence of large number of diabetes patients. The growth of the geriatric population and the increasing number of diabetic patients in Asia Pacific is anticipated to boost the market growth during forecast period.
Major players dominating the global diabetes disposable insulin pen market include B. Braun Melsungen AG, BD, Eli Lilly and Company, MTD Medical Technology and Devices S.A. (HTL-STREFA and Pikdare S.p.A.), Novo Nordisk A/S, Owen Mumford Ltd, sanofi-aventis U.S. LLC, and Ypsomed AG.
The report titled “Diabetes Disposable Insulin Pen Market - Global Market Share, Trends, Analysis and Forecasts, 2023-2032”, wherein 2021 is historic period, 2022 is the base year, and 2023 to 2032 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the global diabetes disposable insulin pen market.
Furthermore, the report would reflect on the key developments, global & regional sales network, business strategies, security & exchange overview, research & development activities, production facilities, product portfolio, employee strength, and key executive, for all the players considered under the scope of study.
For instance, Ypsomed AG reported revenues of US$ 462.2 Million in 2018 and the segment and geographic analysis of the company indicates that Ypsomed Diabetes Care business segment is the dominating segment of the company, with Europe being the major revenue generating region.
The global diabetes disposable insulin pens market is segmented on the basis of diabetes type, distribution channel and geography. Based on diabetes type, the global diabetes disposable insulin pens market is segmented into Type 1 diabetes, and Type 2 diabetes. Based on distribution channel, the global diabetes disposable insulin pens market is segmented into hospitals, clinics, chemists and others. Based on geography, the global diabetes disposable insulin pens market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America.
Additionally, the study provides in-depth analysis of prominent players holding major share in the market with a focus on all operating business segment, and would identify the segment of the company focusing on diabetes disposable insulin pen products.
Further, market share of manufacturing companies in the global diabetes disposable insulin pen market would also be calculated. For instance, Ypsomed AG operates through three business segments namely Ypsomed Diabetes Care, Ypsomed Delivery Systems, and others.
Moreover, Ypsomed Diabetes Care business unit of the company deals with diabetes disposable insulin pen, with a revenue contribution of US$ 285.6 Million. The report takes into consideration the key competitive information such as business strategy, product portfolio, key development, SWOT analysis, and research and development focus of all the Diabetes Disposable Insulin Pen companies.
Furthermore, the global Diabetes Disposable Insulin Pen market study would take into consideration the participants engaged throughout the supply chain and value chain of the market, along with their contribution. Product portfolio would focus on all the products under the Diabetes Disposable Insulin Pen market business segment of the company.
Similarly, the recent development section would focus on the latest developments of company such as strategic alliances and partnerships, merger and acquisition, new product launched and geographic expansion in the global Diabetes Disposable Insulin Pen marketplace.
For instance, in December 2019, Eli Lilly and Company has announced a global commercialization agreement to integrate DexCom, Inc. products into Lilly's personalized diabetes management system, currently in development to advance the treatment of diabetes. The key players in the global diabetes disposable insulin pen market are focused on developing advanced, and effective products in order to gain competitive edge in the global market.
Market Segmentation:
By Diabetes type
- Type 1 diabetes
- Type 2 diabetes
By Distribution channel
- hospitals
- clinics
- chemists
- others
By Geography
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- South America
